Leipziger Jens
Department of Physiology, The Water and Salt Research Center, Aarhus University, 8000 Aarhus C, Denmark.
Am J Physiol Renal Physiol. 2003 Mar;284(3):F419-32. doi: 10.1152/ajprenal.00075.2002.
P2 membrane receptors are specifically activated by extracellular nucleotides like ATP, ADP, UTP, and UDP. P2 receptors are subdivided into metabotropic P2Y and ionotropic P2X receptors. They are expressed in all tissues and induce a variety of biological effects. In epithelia, they are found in both the basolateral and the luminal membranes. Their widespread luminal expression in nearly all transporting epithelia and their effect on transport are summarized. The P2Y(2) receptor is a prominent luminal receptor in many epithelia. Other luminal P2 receptors include the P2X(7), P2Y(4), and P2Y(6) receptors. Functionally, luminal P2Y(2) receptor activation elicits differential effects on ion transport. In nearly all secretory epithelia, intracellular Ca(2+) concentration-activated ion conductances are stimulated by luminal nucleotides to induce Cl(-), K(+), or HCO(3)(-) secretion. This encompasses respiratory and various gastrointestinal epithelia or tissues like the conjunctiva of the eye and the epithelium of sweat glands. In the distal nephron, all active transport processes appear to be inhibited by luminal nucleotides. P2Y(2) receptors inhibit Ca(2+) and Na(+) absorption and K(+) secretion. Commonly, in all steroid-sensitive epithelia (lung, distal nephron, and distal colon), luminal ATP/UTP inhibits epithelial Na(+) channel-meditated Na(+) absorption. ATP is readily released from epithelial cells onto their luminal aspect, where ecto-nucleotidases promote their metabolism. Adenosine generated by the action of 5'-nucleotidase may elicit further effects on ion transport, often opposite those of ATP. ATP release from epithelia continues to be poorly understood. Integrated functional concepts for luminal P2 receptors are suggested: 1) luminal P2 receptors are part of an epithelial "secretory" defense mechanism; 2) they may be involved in the regulation of cell volume when transcellular solute transport is out of balance; 3) ATP and adenosine may be important autocrine/paracrine regulators mediating cellular protection and regeneration after ischemic cell damage; and 4) ATP and adenosine have been suggested to mediate renal cyst growth and enlargement in polycystic kidney disease.
P2膜受体可被细胞外核苷酸如ATP、ADP、UTP和UDP特异性激活。P2受体可细分为代谢型P2Y受体和离子型P2X受体。它们在所有组织中均有表达,并可诱导多种生物学效应。在上皮组织中,它们存在于基底外侧膜和管腔膜中。总结了它们在几乎所有转运上皮组织中的广泛管腔表达及其对转运的影响。P2Y(2)受体是许多上皮组织中一种重要的管腔受体。其他管腔P2受体包括P2X(7)、P2Y(4)和P2Y(6)受体。在功能上,管腔P2Y(2)受体激活对离子转运产生不同的影响。在几乎所有分泌性上皮组织中,管腔核苷酸可刺激细胞内Ca(2+)浓度激活的离子电导,从而诱导Cl(-)、K(+)或HCO(3)(-)分泌。这包括呼吸道和各种胃肠道上皮组织或如眼结膜和汗腺上皮等组织。在远端肾单位,所有主动转运过程似乎均受到管腔核苷酸的抑制。P2Y(2)受体抑制Ca(2+)和Na(+)的重吸收以及K(+)的分泌。通常,在所有类固醇敏感的上皮组织(肺、远端肾单位和远端结肠)中,管腔ATP/UTP抑制上皮钠通道介导的Na(+)重吸收。ATP很容易从上皮细胞释放到其管腔表面,在那里胞外核苷酸酶促进其代谢。5'-核苷酸酶作用产生的腺苷可能对离子转运产生进一步影响,通常与ATP的作用相反。上皮细胞释放ATP的机制仍知之甚少。提出了管腔P2受体的综合功能概念:1)管腔P2受体是上皮“分泌性”防御机制的一部分;2)当跨细胞溶质转运失衡时,它们可能参与细胞体积的调节;3)ATP和腺苷可能是介导缺血性细胞损伤后细胞保护和再生的重要自分泌/旁分泌调节因子;4)ATP和腺苷被认为可介导多囊肾病中肾囊肿的生长和扩大。